Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

LON/0HF3 stock hub

LON/0HF3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HF3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

37.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HF3

In the news

Latest news · LON/0HF3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.1

P25 12.9P50 16.9P75 23.5

Trailing P/E19.3

P25 15.9P50 22.9P75 35.8

ROE107.1

P25 -54.2P50 2.1P75 13.7

ROIC23.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HF3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	51,000
Employees Change	5,000%
Employees Change Percent	10.87
Enterprise value	$46.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Distribution
Isin	US03073E1055
Last refreshed	2026-05-10
Market cap	$37.3B
Price	$265
Price currency	USD
Rev Per Employee	5,079,816.76x
Sector	Healthcare
Sic	5122
Symbol	lon/0HF3
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.18%
EV Earnings	24.3x
EV/EBIT	14.99x
EV/EBITDA	11.26x
EV/FCF	39.74x
EV/Sales	0.19x
FCF yield	3.17%
Forward P/E	14.06x
P/B ratio	13.73x
P/E ratio	19.31x
P/S ratio	0.15x
PE Ratio10 Y	21.84x
PE Ratio3 Y	28.46x
PE Ratio5 Y	24.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.3%
EBITDA Margin	1.61%
FCF margin	0.47%
Gross margin	3.8%
Gross Profit	$9.4B
Gross Profit Growth	22.5%
Gross Profit Growth Q	24.84%
Gross Profit Growth3 Y	14.13%
Gross Profit Growth5 Y	17.55%
Net Income	$1.9B
Net Income Growth	50.51%
Net Income Growth Q	128.64%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	16.38%
Pretax Margin	1.07%
Profit Margin	0.78%
Profit Per Employee	$39,390
Profitable Years	5
ROA	3.49
Roa5y	2.99
ROCE	16.7
ROE	107.1
ROIC	23.2
Roic5y	57.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.6%
Cagr3y	17.55%
Cagr5y	18.71%
Div CAGR3	3%
Div CAGR5	5.4%
EPS Growth	52.02
EPS Growth Q	128.3
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	18.86
FCF Growth	-56.42%
FCF Growth Q	-63.6%
FCF Growth3 Y	-13.97%
FCF Growth5 Y	3.95%
OCF Growth	-44.63%
OCF Growth Q	-60.06%
OCF Growth10 Y	-5.28%
OCF Growth3 Y	-7.89%
OCF Growth5 Y	6.51%
Revenue Growth	5.95x
Revenue Growth Q	3.85x
Revenue Growth Quarters	50x
Revenue Growth Years	12x
Revenue Growth3 Y	9.91x
Revenue Growth5 Y	10.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$4.3
Assets	$61.8B
Cash	$1.6B
Current Assets	$39B
Current Liabilities	$41.2B
Debt	$11.4B
Debt EBITDA	$2.66
Debt Equity	$4.21
Debt FCF	$9.69
Equity	$2.7B
Interest Coverage	8.99
Liabilities	$59.1B
Long Term Assets	$22.9B
Long Term Liabilities	$17.9B
Net Cash	$-9.8B
Net Cash By Market Cap	$-26.24
Net Debt EBITDA	$2.44
Net Debt Equity	$3.6
Net Debt FCF	$8.29
Tangible Book Value	$-14.5B
Tangible Book Value Per Share	$-74.38
WACC	6.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.95
Inventory Turnover	16.23
Net Working Capital	$-3.4B
Quick ratio	0.48
Working Capital	$-2.3B
Working Capital Turnover	$-50.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.91%
Dividend Growth	2.27%
Dividend Growth Years	4%
Dividend per share	$1.72
Dividend Years	9
Dividend Yield	0.65%
Ex Div Date	2026-02-13
Last Dividend	$0.44
Payout Frequency	Quarterly
Payout Ratio	17.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.59%
200-day SMA	327.3
3Y total return	62.44%
50-day SMA	324.8
50-day SMA vs 200-day SMA	50under200
5Y total return	135.69%
All Time High	381.3
All Time High Change	-30.63%
All Time High Date	2026-03-02
All Time Low	71.98
All Time Low Change	267.46%
All Time Low Date	2018-12-24
ATR	15.81
Beta	0.65
Ch YTD	-22.28
High	265.9
High52	381.3
High52 Date	2026-03-02
High52ch	-30.63%
Low	253.6
Low52	245.8
Low52 Date	2026-05-06
Low52ch	7.62%
Ma50ch	-18.56%
Price vs 200-day SMA	-19.19%
RSI	24.26
RSI Monthly	46.05
RSI Weekly	28.04
Sharpe ratio	-0.28x
Sortino ratio	-0.19
Total Return	1.55%
Tr YTD	-22.16
Tr1m	-17.42%
Tr1w	-13.27%
Tr3m	-26.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$3.2B
Operating Income Growth	34.13
Operating Income Growth Q	34.49
Operating Income Growth3 Y	19.3
Operating Income Growth5 Y	12.65
Operating margin	1.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184,024,354%
Net Borrowing	3,020,557,839
Shares Insiders	0.38%
Shares Institutions	96.21%
Shares Qo Q	0.03%
Shares Yo Y	-0.91%
Short Ratio	3.17

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.1B
Average Volume	458.05x
Bv Per Share	13.22
CAPEX	$-543.8M
Ch1m	-17.42
Ch1w	-13.27
Ch1y	-13.21
Ch3m	-26.18
Ch3y	58.23
Ch5y	123.6
Ch6m	-26.75
Change	3.09%
Change From Open	1.73
Close	256.6
Days Gap	1.34
Depreciation Amortization	761,426,408.2
Dollar Volume	201,020
Earnings Date	2026-05-06
EBIT	$3.2B
EBITDA	$4B
EPS	$9.89
F Score	5
FCF	$1.2B
FCF EV Yield	2.52x
Financing CF	2,691,062,870
Fiscal Year End	September
Founded	1,871
Goodwill	12,068,263,048.9
Graham Number	77.04281
Graham Upside	-70.87
Income Tax	$722.6M
Investing CF	-4,339,999,087
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	$224
Lynch Upside	-15.19
Ma150	338.6
Ma150ch	-21.87%
Ma20	303.8
Ma20ch	-12.93%
Net CF	43,693,469
Open	260
P FCF Ratio	31.59
P OCF Ratio	21.63
Payment Date	2026-03-02
Position In Range	88.4
Ppne	2,057,814,112.4
Price Date	2026-05-08
Price EBITDA	$9.29
Relative Volume	1.81x
Revenue	248,911,021,031x
SBC By Revenue	0.04x
Share Based Comp	108,433,202
Tax By Revenue	0.29x
Tax Rate	27.21%
Tr6m	-26.51%
Volume	760
Z Score	4.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0HF3 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$1.72 annual per share

Payout ratio

+17.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.4%

4 consecutive years of growth

Total shareholder yield

+1.6%

Next ex-dividend date: 2026-02-13

Performance

LON/0HF3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HF3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+96.2%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HF3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.3

Below 30: short-term oversold

Price vs 200-day MA

-19.2%

50/200-day relationship not available

Beta (5Y)

0.65

Less volatile than the market

Sharpe ratio

-0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HF3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HF3 stock rating?

lon/0HF3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HF3 analysis?

The full report lives at /stocks/lon/0HF3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HF3?

The latest report frames lon/0HF3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HF3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.